<DOC>
	<DOCNO>NCT00570622</DOCNO>
	<brief_summary>The purpose study investigate response pioglitazone hepatic venous pressure gradient peripheral vascular responsiveness vasoconstrictor patient advance ( Child´s Grade B C ) cirrhosis .</brief_summary>
	<brief_title>Effect Pioglitazone Portal Systemic Hemodynamics Patients With Advanced Cirrhosis</brief_title>
	<detailed_description>Cirrhotic liver disease associate portal hypertension include elevate portal pressure well hyperdynamic circulation low peripheral vascular resistance . Endothelial nitric ( NO ) release impair liver microvasculature , upregulation eNOS activity cirrhotic liver may constitute new strategy correct increase hepatic vascular tone patient . In contrary impaired endothelium-dependent relaxation ( endothelial dysfunction ) NO deficiency cirrhotic liver , systemic splanchnic circulation cirrhotic patient characterize increased vascular tone hyporesponsiveness vasoconstrictor . In addition increase insulin sensitivity , thiazolidinediones , like pioglitazone decrease oxidative stress inflammation improve endothelial function . In randomized control , parallel group double-blind study 20 Patients advanced ( Child´s Grade B C ) liver cirrhosis receive pioglitazone placebo nine day . Portal hemodynamics forearm blood flow response measure baseline pioglitazone/placebo investigate effect pioglitazone group patient .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Cirrhosis , grade B C ( ChildPugh score ) History hypersensitivity trial drug contrast agent drug similar chemical structure Treatment vasoactive nonsteroidal antiinflammatory drug systemic antibiotic one week study Exclusion criterion hepatic hemodynamic investigation Cardiac , renal respiratory failure Previous surgical transjugular intrahepatic portosystemic shunt Insulindependent diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>pioglitazone</keyword>
</DOC>